
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+2
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. The company was founded on breakthrough computationally-designed virus like particle technology, exclusively licensed for a variety of infectious disease indications from the Institute for Protein Design at the University of Washington. Icosavax is located in Seattle. Icosavax is a member of the AstraZeneca Group
Vaccine development,infectious disease,vlps,rsv,respiratory syncytial virus,vaccines,and vaccine
Icosavax, inc operates in the Biotechnology research industry.
Icosavax, inc's revenue is 11m - 100m
Icosavax, inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.